CHMP recommends a label update for Novo Nordisk's Ozempic after the STRIDE study shows walking improvements in T2D patients with PAD.

A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today reported positive results from a pivotal ...

The studies conducted were open-label, randomized, balanced, single oral dose, two-treatment, two-period, two-sequence, crossover bioequivalence studies in normal, healthy, adult, human subjects ...

A team of researchers at Rowan University has developed an injectable biomaterial that could significantly improve recovery ...

Boehringer Ingelheim recently announced the start of the THULITE phase II clinical study ( NCT06962839 ). THULITE will ...

Celltrion USA launches 2 denosumab biosimilars, Stoboclo and Osenvelt, enhancing treatment options for osteoporosis and ...

This study was designed to investigate, in accordance with international regulatory guidelines, the bioequivalence of two omeprazole products following single- and multiple-dose administration, as ...

A new study suggests that the long-necked, fuzzy mammals could be our secret weapon against COVID-19.

EYP-1901 shows promising results in reducing treatment burden for diabetic macular edema, offering sustained improvements in ...

Certain disposable e-cigarettes, often sold in nostalgia-inducing candy flavors, could be unhealthier than traditional cigarettes by some measures, a new study shows.

Individuals at risk for sexually acquired HIV have a new injectable option for preexposure prophylaxis (PrEP) with the US Food and Drug Administration’s (FDA’s) approval of lenacapavir ...